Holzer Clinic, LLC

Holzer Clinic, LLC was paid $55.86M by Medicaid between Jan 2018 and Dec 2024, across 406 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 41% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	255,622	$8.06M
2019	254,647	$8.04M
2020	211,731	$6.83M
2021	381,390	$7.47M
2022	598,651	$8.22M
2023	1,013,719	$9.15M
2024incomplete	697,150	$8.09M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	41%	519,852	474,427	$23.17M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	15%	249,550	219,333	$8.19M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	10%	88,198	83,718	$5.61M
99051		3.1%	89,751	82,860	$1.74M
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	2.2%	18,758	17,377	$1.21M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	1.6%	23,030	20,609	$887K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	1.3%	18,607	17,154	$732K
74177	Computed tomography, abdomen and pelvis; with contrast material	1.1%	12,577	11,557	$605K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	11,028	10,137	$516K
70450	Computed tomography, head or brain; without contrast material	<1%	15,939	14,383	$499K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	11,448	10,444	$476K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	13,043	8,567	$476K

394 more codes

93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	63,751	$460K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	9,215	$445K
71275	Computed tomographic angiography, chest, with contrast material	<1%	5,228	$395K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	2,651	$383K
20610		<1%	12,434	$374K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	16,085	$362K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	8,224	$334K
71046	Radiologic examination, chest; 2 views	<1%	30,634	$295K
99285	Emergency room visit (most serious)	<1%	3,447	$284K
99215	Doctor's office visit, returning patient (complex)	<1%	4,800	$266K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	8,525	$258K
99232	Hospital visit by a doctor, follow-up day	<1%	13,357	$253K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	2,416	$246K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	4,502	$211K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	2,664	$204K
71045	Radiologic examination, chest; single view	<1%	32,118	$201K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	8,371	$190K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	11,279	$187K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	3,457	$179K
J7328	Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg	<1%	997	$166K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	5,683	$159K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,926	$132K
98940		<1%	9,601	$130K
98941	Chiropractic manipulative treatment; spinal, 3-4 regions	<1%	6,237	$124K
71250		<1%	4,453	$123K
80053	Comprehensive metabolic panel	<1%	14,424	$120K
76830	Ultrasound, transvaginal	<1%	3,413	$114K
36415	Collection of venous blood by venipuncture	<1%	32,914	$114K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	17,806	$109K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	2,052	$106K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,407	$104K
64615		<1%	1,190	$102K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	2,291	$96K
84443	Thyroid stimulating hormone (TSH)	<1%	8,394	$96K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	4,536	$95K
73630		<1%	11,566	$94K
80061	Lipid panel	<1%	10,376	$91K
90472	Immunization administration, each additional vaccine (list separately)	<1%	4,239	$90K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	5,123	$90K
73562		<1%	9,624	$89K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	7,081	$82K
80050	General health panel	<1%	2,526	$80K
92557		<1%	4,041	$80K
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	870	$75K
72110		<1%	4,773	$72K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	122	$70K
99238	Hospital discharge day management, 30 minutes or less	<1%	2,238	$70K
72131		<1%	2,050	$68K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	387	$65K
59025	Fetal non-stress test	<1%	2,657	$65K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	8,063	$65K
95886		<1%	2,503	$64K
73610		<1%	7,441	$62K
92015	Determination of refractive state	<1%	4,757	$61K
83036	Hemoglobin; glycosylated (A1C)	<1%	9,136	$61K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	837	$58K
99442		<1%	2,824	$57K
88342		<1%	2,342	$57K
73030		<1%	6,633	$56K
73130		<1%	6,543	$56K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	217	$56K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,739	$55K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	175	$55K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,130	$54K
88141		<1%	1,841	$51K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	3,684	$46K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	1,665	$40K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	2,064	$40K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,397	$39K
20552		<1%	2,112	$39K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,390	$39K
70486		<1%	1,026	$39K
99152		<1%	771	$37K
97597		<1%	5,055	$36K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	195	$36K
94060		<1%	2,909	$36K
73110		<1%	4,081	$35K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	1,333	$35K
0240U		<1%	738	$35K
00840		<1%	294	$35K
74018		<1%	4,112	$34K
J7321	Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose	<1%	403	$34K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	1,499	$31K
92567		<1%	3,778	$31K
93458		<1%	222	$30K
93016		<1%	1,492	$29K
76536		<1%	1,289	$29K
72128		<1%	818	$28K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	941	$27K
82607		<1%	3,315	$27K
90686		<1%	6,495	$26K
88307		<1%	367	$25K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	3,789	$25K
94010		<1%	2,832	$24K
99221		<1%	902	$24K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	515	$24K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	75	$23K
80048	Basic metabolic panel (calcium, ionized)	<1%	3,288	$23K
90961		<1%	443	$22K
99441		<1%	2,033	$22K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	480	$22K
J7323	Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose	<1%	263	$22K
99460		<1%	259	$21K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	1,907	$21K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	130	$21K
99222	Initial hospital care, per day, moderate complexity	<1%	372	$20K
73502		<1%	2,232	$20K
82746		<1%	2,808	$20K
0002A		<1%	485	$19K
87086	Culture, bacterial; quantitative colony count, urine	<1%	2,965	$19K
76819	Fetal biophysical profile; without non-stress testing	<1%	627	$19K
0001A		<1%	488	$19K
93971		<1%	1,011	$19K
88142		<1%	1,010	$18K
93018		<1%	1,490	$18K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	499	$17K
99217		<1%	658	$17K
99177		<1%	2,003	$16K
84439		<1%	2,355	$16K
95024		<1%	675	$16K
72050		<1%	1,086	$16K
99443		<1%	575	$15K
99309	Subsequent nursing facility care, per day, low to moderate complexity	<1%	3,516	$15K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	758	$15K
99218		<1%	703	$15K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	515	$15K
V5266	Battery for use in hearing device	<1%	3,809	$14K
99239	Hospital discharge day management, more than 30 minutes	<1%	528	$14K
95811		<1%	191	$14K
90960	End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits	<1%	348	$14K
76642		<1%	490	$13K
95912		<1%	165	$13K
93227		<1%	474	$13K
93244		<1%	732	$13K
87186		<1%	1,525	$13K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	98	$12K
94726		<1%	2,864	$11K
81001		<1%	3,593	$11K
94729		<1%	2,864	$11K
87077		<1%	1,534	$11K
69210		<1%	702	$10K
90962		<1%	223	$10K
76770		<1%	442	$10K
88304		<1%	1,023	$10K
90837	Psychotherapy session, about an hour	<1%	120	$10K
31575		<1%	230	$10K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	140	$10K
86803		<1%	895	$9K
71271		<1%	194	$9K
62323		<1%	121	$9K
92133		<1%	1,228	$9K
11750		<1%	118	$8K
81025		<1%	1,228	$8K
99174		<1%	640	$8K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	256	$7K
73080		<1%	1,160	$7K
83550		<1%	1,330	$7K
89190		<1%	1,604	$7K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	116	$7K
00731		<1%	140	$7K
87340		<1%	925	$7K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	89	$6K
95909		<1%	135	$6K
83540		<1%	1,493	$6K
74019		<1%	626	$6K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	111	$6K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	373	$6K
92504		<1%	1,426	$6K
82570		<1%	1,337	$6K
0012A		<1%	136	$6K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	73	$6K
99349		<1%	293	$5K
0031A		<1%	171	$5K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	91	$5K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	31	$5K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	49	$5K
95251		<1%	827	$5K
77066	Tomosynthesis, mammo	<1%	159	$5K
86780		<1%	597	$5K
0003A		<1%	54	$5K
86140		<1%	1,378	$5K
0011A		<1%	129	$5K
95911		<1%	66	$5K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	68	$5K
92587		<1%	287	$5K
36573		<1%	107	$4K
93454		<1%	43	$4K
93880		<1%	211	$4K
00813		<1%	55	$4K
90671		<1%	306	$4K
74178		<1%	69	$4K
82043		<1%	786	$4K
73560		<1%	493	$4K
11721		<1%	913	$4K
72072		<1%	369	$3K
86850		<1%	475	$3K
31237		<1%	35	$3K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	66	$3K
85610		<1%	1,200	$3K
90677		<1%	121	$3K
73590		<1%	430	$3K
74022		<1%	218	$3K
G0127	Trimming of dystrophic nails, any number	<1%	1,272	$3K
81003		<1%	1,604	$3K
99225		<1%	234	$3K
82728		<1%	376	$3K
H1000	Prenatal care, at-risk assessment	<1%	151	$3K
90670		<1%	4,971	$3K
93298		<1%	243	$3K
99336		<1%	400	$3K
64493		<1%	96	$3K
92134		<1%	423	$3K
G0179	Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care	<1%	462	$3K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	204	$3K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	90	$3K
87070		<1%	278	$3K
87420		<1%	187	$2K
90656		<1%	188	$2K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	77	$2K
20553		<1%	106	$2K
H1003	Prenatal care, at-risk enhanced service; education	<1%	153	$2K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	54	$2K
00170	Anesthesia for intraoral procedures, including biopsy	<1%	28	$2K
93970		<1%	107	$2K
85652		<1%	1,103	$2K
90715		<1%	339	$2K
99223	Prolong inpt eval add15 m	<1%	38	$2K
73090		<1%	256	$2K
95117		<1%	515	$2K
92002		<1%	110	$2K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	63	$2K
20605		<1%	69	$2K
70496		<1%	37	$2K
81000		<1%	413	$2K
31231		<1%	44	$2K
20550		<1%	61	$2K
82947		<1%	479	$2K
00811		<1%	40	$2K
70491		<1%	28	$2K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	34	$2K
92083		<1%	158	$2K
64632		<1%	48	$2K
83735		<1%	341	$1K
90648		<1%	5,713	$1K
93228		<1%	92	$1K
80306		<1%	129	$1K
90662		<1%	119	$1K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	117	$1K
85018		<1%	461	$1K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	61	$1K
G0008	Administration of influenza virus vaccine	<1%	286	$1K
90832	Psychotherapy session, about 30 minutes	<1%	26	$1K
43235		<1%	16	$1K
90791	Psychiatric diagnostic evaluation	<1%	13	$1K
93272		<1%	33	$997.63
20551		<1%	38	$992.11
99308	Subsequent nursing facility care, per day, straightforward	<1%	345	$988.00
73140		<1%	129	$970.20
70498		<1%	19	$964.87
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	1,162	$964.74
95908		<1%	28	$962.05
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	182	$881.55
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	63	$881.36
90723		<1%	3,440	$870.76
93295		<1%	45	$863.05
83992		<1%	58	$844.78
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	30	$840.88
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	150	$827.19
80346		<1%	40	$825.22
71101		<1%	85	$816.10
90651		<1%	322	$795.30
99401		<1%	26	$792.12
59430		<1%	13	$792.00
96375	Therapeutic injection; each additional sequential IV push	<1%	53	$754.54
64450		<1%	13	$753.23
86038		<1%	91	$738.09
80361		<1%	40	$712.58
99337		<1%	101	$689.43
80363		<1%	32	$672.58
99406		<1%	85	$640.94
99205	Prolong outpt/office vis	<1%	16	$638.04
87522	Neg quan hep c or qual rna	<1%	17	$610.45
88112		<1%	31	$540.00
93294		<1%	44	$539.57
86762		<1%	62	$514.32
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	133	$508.04
86703		<1%	95	$504.37
86706		<1%	57	$502.41
51798		<1%	80	$497.25
98928		<1%	13	$478.96
73564		<1%	45	$472.27
27096		<1%	12	$461.79
86769		<1%	18	$446.57
83690		<1%	107	$439.48
90734		<1%	939	$439.44
84153		<1%	32	$421.24
99335		<1%	65	$419.62
11055		<1%	79	$418.54
93922		<1%	31	$414.90
80350		<1%	40	$413.38
80358		<1%	41	$413.38
80353		<1%	40	$413.38
80324		<1%	40	$413.38
80349		<1%	40	$413.38
80373		<1%	40	$413.38
80348		<1%	40	$413.38
80356		<1%	40	$413.38
80355		<1%	39	$413.38
80365		<1%	40	$413.38
80354		<1%	40	$413.38
52000		<1%	14	$406.02
93280		<1%	41	$383.17
90633		<1%	1,684	$378.16
86666		<1%	30	$374.29
92136		<1%	47	$374.13
99219		<1%	12	$362.63
80368		<1%	32	$358.53
80359		<1%	32	$358.53
80333		<1%	32	$358.53
80367		<1%	32	$358.53
80371		<1%	32	$358.53
80336		<1%	32	$358.53
80372		<1%	32	$358.53
80360		<1%	32	$358.53
80366		<1%	32	$358.53
80369		<1%	32	$358.53
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	1,739	$344.78
80323		<1%	32	$336.31
86757		<1%	30	$324.96
84403		<1%	19	$309.72
99407		<1%	18	$297.11
90710		<1%	319	$296.07
83655		<1%	26	$283.40
84550		<1%	125	$277.34
90474		<1%	25	$241.78
96127		<1%	84	$240.63
99224		<1%	12	$231.17
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	38	$214.93
76882		<1%	28	$212.52
87210		<1%	50	$211.25
86430		<1%	54	$196.32
84702		<1%	18	$189.70
85014		<1%	75	$181.29
95012		<1%	34	$178.53
86376		<1%	24	$174.52
86618		<1%	40	$173.69
85730		<1%	44	$164.69
85027		<1%	34	$161.10
80069		<1%	15	$127.17
86900		<1%	71	$124.15
82150		<1%	71	$123.55
90681		<1%	625	$123.02
86901		<1%	71	$117.15
93000		<1%	12	$113.92
97014		<1%	520	$101.00
99334		<1%	40	$98.48
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	12	$91.74
73565		<1%	12	$85.20
82247		<1%	16	$69.37
77080		<1%	16	$59.37
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	53	$46.41
85007		<1%	13	$41.05
81002		<1%	16	$39.71
99000		<1%	24	$28.00
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	18	$26.84
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	<1%	71	$25.18
1034F		<1%	44,713	$24.51
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	15	$22.99
3078F		<1%	156,012	$19.23
84436		<1%	14	$17.51
84156		<1%	14	$15.14
90696		<1%	207	$10.08
97032		<1%	82	$9.41
97035		<1%	87	$7.98
1036F		<1%	194,951	$5.61
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	14	$1.06
90716		<1%	37	$0.02
90707		<1%	49	$0.01
1160F		<1%	264,530	$0.01
1159F		<1%	236,370	$0.01
1126F		0%	83,797	$0.00
1125F		0%	82,818	$0.00
3075F		0%	19,445	$0.00
3008F		0%	236,842	$0.00
1035F		0%	7,052	$0.00
3074F		0%	164,756	$0.00
3079F		0%	39,944	$0.00
3080F		0%	4,751	$0.00
3725F		0%	112,957	$0.00
3077F		0%	12,634	$0.00
3288F		0%	8,877	$0.00
90649		0%	65	$0.00
90700		0%	50	$0.00
1124F		0%	28	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRODNEY, STOUT (CEO)